Method and system for providing basal profile modification in analyte monitoring and management systems
Method and system for providing basal profile modification in insulin therapy for use with infusion devices includes periodically monitoring the analyte levels of a patient for a predetermined period of time in order to determine, based on the monitored analyte levels, an appropriate modification factor to be incorporated into the underlying basal profile which was running at the time the periodic monitoring of the analyte levels were performed.
1. A method of improving diabetes management with an electronic analyte monitoring and management system comprising a sensor, one or more processing units, and an infusion device, the method comprising:
retrieving from a data storage unit using the one or more processing units, a first medication delivery profile for administration of a medication to a user during a plurality of time segments;
administering the medication with the infusion device according to the first medication delivery profile;
monitoring, using the sensor, an analyte level of the user during the plurality of time segments;
determining, using the one or more processing units, a frequency of the analyte level deviating from a predetermined level during one or more of the plurality of time segments;
determining, using the one or more processing units, a second medication delivery profile for administration of the medication during the one or more of the plurality of time segments when the frequency of the analyte level deviating from the predetermined level exceeds a predetermined threshold; and
administering the medication with the infusion device according to the second medication delivery profile such that the frequency of the analyte level's deviation from the predetermined level is reduced.
2. The method of claim 1 , further comprising outputting a notification associated with the second medication delivery profile.
3. The method of claim 2 , wherein the notification is output visually and/or audibly.
4. The method of claim 1 , wherein the medication is insulin, the analyte level monitored is a glucose level, and administering the medication with the infusion device according to the second medication delivery profile includes one or more of reducing extreme glucose excursions, automating or semi-automating a routine or a regular bolus dosing, or adjusting a mean glucose value.
5. The method of claim 1 , wherein administering the medication with the infusion device according to the second medication delivery profile includes modifying a currently running medication delivery profile prior to its completion.
6. The method of claim 1 , further comprising storing the determined second medication delivery profile in the data storage unit.
7. The method of claim 1 , wherein the first medication delivery profile is based at least in part on the plurality of time segments and one or more patient specific parameters.
8. The method of claim 7 , wherein the medication is insulin, the monitored analyte level is a glucose level, and the one or more patient specific parameters include one or more of an insulin sensitivity, a type of insulin being administered, one or more activities during the plurality of time segments, or carbohydrate intake during the plurality of time segments.
9. The method of claim 1 , wherein the first medication delivery profile is based at least in part on a frequency of bolus dosing of the medication during the plurality of time segments and a level of medication on board.
10. An apparatus, comprising:
an infusion device adapted to administer medication to a user according to instructions from one or more processing units;
the one or more processing units operatively coupled with the infusion device; and
a data storage unit operatively coupled to the one or more processing units, the data storage unit having stored therein executable programming instructions which, when executed by the one or more processing units, are configured to retrieve a first medication delivery profile for administration of a medication during a plurality of time segments from the data storage unit, to cause administration of the medication by the infusion device according to the first medication delivery profile, to monitor an analyte level during the plurality of time segments, to determine a frequency of the analyte level deviating from a predetermined level during one or more of the plurality of time segments, to determine a second medication delivery profile for administration of the medication during the one or more of the plurality of time segments when the frequency of the analyte level deviating from the predetermined level exceeds a predetermined threshold, and to cause administration of the medication by the infusion device according to the second medication delivery profile such that the frequency of the analyte level's deviation from the predetermined level is reduced.
11. The apparatus of claim 10 , further comprising an output unit operatively coupled to the one or more processing units configured to output a notification associated with the second medication delivery profile.
12. The apparatus of claim 11 , wherein the notification is output visually and/or audibly.
13. The apparatus of claim 10 , wherein the medication is insulin, the analyte level monitored is a glucose level, and the determined second medication delivery profile is adapted to reduce extreme glucose excursions, automate or semi-automate a routine or a regular bolus dose, or adjust a mean glucose value.
14. The apparatus of claim 10 , wherein the executable programming instructions stored in the data storage unit, are, when executed by the one or more processing units, further configured to modify a currently running medication delivery profile prior to its completion.
15. The apparatus of claim 10 , wherein the determined second medication delivery profile is stored in the data storage unit.
16. The apparatus of claim 10 , wherein the first medication delivery profile is based at least in part on the plurality of time segments and one or more patient specific parameters.
17. The apparatus of claim 16 , wherein the medication is insulin, the monitored analyte level is a glucose level, and the one or more patient specific parameters include one or more of an insulin sensitivity, a type of insulin being administered, one or more activities during the plurality of time segments, or carbohydrate intake during the plurality of time segments.
18. The apparatus of claim 10 , wherein the first medication delivery profile is based at least in part on a frequency of bolus dosing of the medication during the plurality of time segments and a level of medication on board.